miR-511-3p, embedded in the macrophage mannose receptor gene, contributes to intestinal inflammation

Area of Science:

• Immunology
• Molecular Biology
• Gastroenterology

Background:

• MicroRNA-511-3p (miR-511-3p) is co-regulated with CD206 (macrophage mannose receptor) within the MRC1 gene.
• The roles of CD206 and miR-511-3p in intestinal inflammation remain unclear.
• Macrophages and dendritic cells express CD206 and miR-511-3p.

Purpose of the Study:

• To investigate the roles of CD206 and miR-511-3p in intestinal inflammation using mouse and human models.
• To elucidate the regulatory relationship between miR-511-3p and Toll-like receptor 4 (Tlr4) in macrophages.
• To assess the impact of these molecules on macrophage-mediated inflammatory responses.

Main Methods:

• Utilized CD206-deficient mice and wild-type (WT) controls in experimental colitis models.
• Isolated macrophages from mice for in vitro stimulation with lipopolysaccharides (LPS) and fecal supernatants.
• Performed miR-511-3p overexpression and knockdown experiments in macrophages to assess Tlr4 mRNA levels.
• Analyzed colon biopsies from human subjects for miR-511-3p expression.

Main Results:

• CD206-deficient mice exhibited attenuated experimental colitis, but CD206 antagonists did not replicate this.
• Macrophages from CD206-deficient mice showed reduced miR-511-3p and Tlr4 levels, leading to decreased pro-inflammatory cytokine production.
• miR-511-3p overexpression increased Tlr4 mRNA by 50%, while knockdown decreased it by 60%.
• No significant change in miR-511-3p was observed in colon biopsies from patients responding to anti-TNF therapy.

Conclusions:

• miR-511-3p controls macrophage-mediated responses to microbial stimuli.
• miR-511-3p is a key regulator of intestinal inflammation, partly through its control of Tlr4 expression.
• While CD206 expression may correlate with treatment response, miR-511-3p's direct role in human intestinal inflammation warrants further investigation.